|
|
||||||||
Ann Thorac Surg 1998;66:S12-S16
© 1998 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Address reprint requests to Dr Edmunds, Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104
Presented at "Risk Management in CABG: Significant Surgical Considerations," New Orleans, LA, Jan 24, 1998.
This article reviews the roles of the contact and complement systems and of neutrophils and monocytes in the inflammatory response to cardiopulmonary bypass and open heart operation. These blood proteins and cells, together with other blood elements, produce the vasoactive and cytotoxic substances and microemboli that cause the morbidity associated with cardiopulmonary bypass and open heart operation.
This article has been cited by other articles:
![]() |
S. G Raja and G. D Dreyfus Current Status of Off-pump Coronary Artery Bypass Surgery Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 164 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eggum, T. Ueland, T. E. Mollnes, V. Videm, P. Aukrust, A. E. Fiane, and H. L. Lindberg Effect of Perfusion Temperature on the Inflammatory Response During Pediatric Cardiac Surgery Ann. Thorac. Surg., February 1, 2008; 85(2): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Feng and F. W. Sellke Invited commentary Ann. Thorac. Surg., January 1, 2008; 85(1): 87 - 88. [Full Text] [PDF] |
||||
![]() |
A. Radaelli, C. Loardi, M. Cazzaniga, G. Balestri, C. DeCarlini, M. G. Cerrito, E. N. Cusa, L. Guerra, S. Garducci, D. Santo, et al. Inflammatory Activation During Coronary Artery Surgery and Its Dose-Dependent Modulation by Statin/ACE-Inhibitor Combination Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2750 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Amirghofran and A. Emami Nia Right Heart Operations Without Cardiopulmonary Bypass: The Use of Temporary Total Cavopulmonary Connection Ann. Thorac. Surg., October 1, 2007; 84(4): 1414 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Echahidi, D. Mohty, P. Pibarot, J.-P. Despres, G. O'Hara, J. Champagne, F. Philippon, P. Daleau, P. Voisine, and P. Mathieu Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery Circulation, September 11, 2007; 116(11_suppl): I-213 - I-219. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Echahidi, P. Pibarot, J.-P. Despres, J.-M. Daigle, D. Mohty, P. Voisine, R. Baillot, and P. Mathieu Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery J. Am. Coll. Cardiol., August 28, 2007; 50(9): 843 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Warren, C. Alexiou, R. Massey, D. Leff, S. Purkayastha, J. Kinross, A. Darzi, and T. Athanasiou The effects of various leukocyte filtration strategies in cardiac surgery Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 665 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Novitzky, A L. Shroyer, J. F Collins, G. O McDonald, J. Lucke, B. Hattler, E. Kozora, D. D Bradham, J. Baltz, F. L Grover, et al. A study design to assess the safety and efficacy of on-pump versus off-pump coronary bypass grafting: the ROOBY trial Clinical Trials, February 1, 2007; 4(1): 81 - 91. [Abstract] [PDF] |
||||
![]() |
C. S. Rinder, M. J. Smith, H. M. Rinder, D. N. Cortright, R. M. Brodbeck, J. E. Krause, and B. R. Smith Leukocyte Effects of C5a-Receptor Blockade During Simulated Extracorporeal Circulation Ann. Thorac. Surg., January 1, 2007; 83(1): 146 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Stevens, S. Fortier, M.-C. Aubin, I. El-Hamamsy, S. Maltais, M. Carrier, and L. P. Perrault Effect of tetrahydrobiopterin on selective endothelial dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary bypass. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 464 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Dong, Y. Liu, M. Du, Q. Wang, C. T. Yu, and X. Fan P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 77 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wiebe, H. Baraki, P. Macchiarini, and A. Haverich Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 571 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Schultz, T. Karamlou, J. Swanson, I. Shen, and R. M. Ungerleider Hypothermic Low-Flow Cardiopulmonary Bypass Impairs Pulmonary and Right Ventricular Function More Than Circulatory Arrest Ann. Thorac. Surg., February 1, 2006; 81(2): 474 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Cavalca, E. Sisillo, F. Veglia, E. Tremoli, G. Cighetti, L. Salvi, A. Sola, L. Mussoni, P. Biglioli, G. Folco, et al. Isoprostanes and Oxidative Stress in Off-Pump and On-Pump Coronary Bypass Surgery Ann. Thorac. Surg., February 1, 2006; 81(2): 562 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C Whitaker, J. Stygall, M. J. Harrison, I. J Mackie, M. Kemp, J. Hooper, W. B Pugsley, and S. P Newman Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation Perfusion, January 1, 2006; 21(1): 55 - 60. [Abstract] [PDF] |
||||
![]() |
J Cosgrave, J B Foley, R Kelly, E McGovern, K Bennett, V Young, M Tolan, P Crean, D Kelleher, and M J Walsh Perioperative serum inflammatory response and the development of atrial fibrillation after coronary artery bypass surgery Heart, November 1, 2005; 91(11): 1475 - 1476. [Full Text] [PDF] |
||||
![]() |
S. R. Leal-Noval, R. Amaya, A. Herruzo, A. Hernandez, A. Ordonez, A. Marin-Niebla, and P. Camacho Effects of a Leukocyte Depleting Arterial Line Filter on Perioperative Morbidity in Patients Undergoing Cardiac Surgery: A Controlled Randomized Trial Ann. Thorac. Surg., October 1, 2005; 80(4): 1394 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fung, R. R. Fiscus, A. P. C. Yim, G. D. Angelini, and A. A. Arifi The Potential Use of Type-5 Phosphodiesterase Inhibitors in Coronary Artery Bypass Graft Surgery Chest, October 1, 2005; 128(4): 3065 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsuzaki, Y. Hiramatsu, S. Homma, S. Sato, O. Shigeta, and Y. Sakakibara Sivelestat Reduces Inflammatory Mediators and Preserves Neutrophil Deformability During Simulated Extracorporeal Circulation Ann. Thorac. Surg., August 1, 2005; 80(2): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Cannon, S. R. Mehta, and S. F. Aranki Balancing the Benefit and Risk of Oral Antiplatelet Agents in Coronary Artery Bypass Surgery Ann. Thorac. Surg., August 1, 2005; 80(2): 768 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parolari, L. Mussoni, M. Frigerio, M. Naliato, F. Alamanni, A. Galanti, G. Fiore, F. Veglia, E. Tremoli, P. Biglioli, et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, Y. Hiramatsu, S. Homma, M. Sato, S. Sato, S. Endo, and Y. Sohara Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 346 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Fontes, J. P. Mathew, H. M. Rinder, D. Zelterman, B. R. Smith, C. S. Rinder, and the Multicenter Study of Perioperative Ischemia (M Atrial Fibrillation After Cardiac Surgery/Cardiopulmonary Bypass Is Associated with Monocyte Activation Anesth. Analg., July 1, 2005; 101(1): 17 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Williams, R. J. Ing, J. P. Hart, J. Jaggers, F. H. Kern, D. M. Craig, and S. V. Pizzo Soluble {alpha}2-macroglobulin receptor is increased in endotracheal aspirates from infants and children after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1098 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hiramatsu, S. Homma, Y. Sato, S. Sato, K. Matsuzaki, O. Shigeta, and Y. Sakakibara Nafamostat Preserves Neutrophil Deformability and Reduces Microaggregate Formation During Simulated Extracorporeal Circulation Ann. Thorac. Surg., April 1, 2005; 79(4): 1326 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Lappegard, J. Riesenfeld, O.-L. Brekke, G. Bergseth, J. D. Lambris, and T. E. Mollnes Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface-Induced Eicosanoid Production Ann. Thorac. Surg., March 1, 2005; 79(3): 917 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cagli, M. M. Ulas, K. Ozisik, A. Kale, V. Bakuy, M. Emir, M. Balci, M. Topbas, E. Sener, and O. Tasdemir The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass Perfusion, January 1, 2005; 20(1): 45 - 51. [Abstract] [PDF] |
||||
![]() |
G. J Murphy, R. Ascione, and G. D Angelini Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur. Heart J., December 1, 2004; 25(23): 2077 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alexiou, A. T.M. Tang, S. V. Sheppard, M. P. Haw, R. Gibbs, and D. C. Smith A Prospective Randomized Study to Evaluate the Effect of Leukodepletion on the Rate of Alveolar Production of Exhaled Nitric Oxide During Cardiopulmonary Bypass Ann. Thorac. Surg., December 1, 2004; 78(6): 2139 - 2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruel, T. A. Khan, P. Voisine, C. Bianchi, and F. W. Sellke Vasomotor dysfunction after cardiac surgery Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 1002 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Desai, M. P. Pelletier, H. R. Mallidi, G. T. Christakis, G. N. Cohen, S. E. Fremes, and B. S. Goldman Why Is Off-Pump Coronary Surgery Uncommon in Canada? Results of a Population-Based Survey of Canadian Heart Surgeons Circulation, September 14, 2004; 110(11_suppl_1): II-7 - II-12. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wynne and M. Botti Postoperative Pulmonary Dysfunction in Adults After Cardiac Surgery With Cardiopulmonary Bypass: Clinical Significance and Implications for Practice Am. J. Crit. Care., September 1, 2004; 13(5): 384 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Berdat, E. Eichenberger, J. Ebell, J.-P. Pfammatter, M. Pavlovic, C. Zobrist, E. Gygax, U. Nydegger, and T. Carrel Elimination of proinflammatory cytokines in pediatric cardiac surgery: Analysis of ultrafiltration method and filter type J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1688 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Puskas, W. H. Williams, E. M. Mahoney, P. R. Huber, P. C. Block, P. G. Duke, J. R. Staples, K. E. Glas, J. J. Marshall, M. E. Leimbach, et al. Off-Pump vs Conventional Coronary Artery Bypass Grafting: Early and 1-Year Graft Patency, Cost, and Quality-of-Life Outcomes: A Randomized Trial JAMA, April 21, 2004; 291(15): 1841 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, J. D. Lambris, V. Videm, and T. E. Mollnes Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation Ann. Thorac. Surg., March 1, 2004; 77(3): 932 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mirsadraee, A. Fraser, M. A Kerr, T. E James, and C. van Doorn Inflammatory response in an immunosuppressed patient with Wegener's granulomatosis Perfusion, March 1, 2004; 19(2): 127 - 131. [Abstract] [PDF] |
||||
![]() |
Y. Kaminishi, Y. Hiramatsu, Y. Watanabe, Y. Yoshimura, and Y. Sakakibara Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass Ann. Thorac. Surg., February 1, 2004; 77(2): 644 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wehlin, J. Vedin, J. Vaage, and J. Lundahl Activation of complement and leukocyte receptors during on- and off pump coronary artery bypass surgery Eur. J. Cardiothorac. Surg., January 1, 2004; 25(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vedin, U. Jensen, A. Ericsson, C. Bitkover, S. Samuelsson, F. Bredin, and J. Vaage Cardiovascular function during the first 24 hours after off pump coronary artery bypass grafting-a prospective, randomized study Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 489 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshimura, Y. Hiramatsu, Y. Sato, S. Homma, Y. Enomoto, T. Jikuya, and Y. Sakakibara ONO-6818, a novel, potent neutrophil elastase inhibitor, reduces inflammatory mediators during simulated extracorporeal circulation Ann. Thorac. Surg., October 1, 2003; 76(4): 1234 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Magee, L. P. Coombs, E. D. Peterson, and M. J. Mack Patient Selection and Current Practice Strategy for Off-pump Coronary Artery Bypass Surgery Circulation, September 9, 2003; 108(90101): II-9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Biglioli, A. Cannata, F. Alamanni, M. Naliato, M. Porqueddu, M. Zanobini, E. Tremoli, and A. Parolari Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Giomarelli, S. Scolletta, E. Borrelli, and B. Biagioli Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10 Ann. Thorac. Surg., July 1, 2003; 76(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shum-Tim, C. I. Tchervenkov, E. Laliberte, A.-M. Jamal, T. Nimeh, C.-Y. Luo, B. Bittira, and A. Philip Timing of steroid treatment is important for cerebral protection during cardiopulmonary bypass and circulatory arrest: minimal protection of pump prime methylprednisolone Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 125 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L.K. Sheil, T. B. Cartmill, G. R. Nunn, G. F. Sholler, O. T. Raitakari, and D. S. Celermajer Contrast echocardiography: potential for the in-vivo study of pediatric myocardial preservation Ann. Thorac. Surg., May 1, 2003; 75(5): 1542 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshimura, Y. Hiramatsu, Y. Sato, S. Homma, Y. Enomoto, Y. Kikuchi, and Y. Sakakibara Activated neutrophils and platelet microaggregates impede blood filterability through microchannels during simulated extracorporeal circulation Ann. Thorac. Surg., April 1, 2003; 75(4): 1254 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Rinder, M. Fontes, J. P. Mathew, H. M. Rinder, and B. R. Smith Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury Ann. Thorac. Surg., March 1, 2003; 75(3): 899 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ninomiya, K. Miyaji, and S. Takamoto Influence of PMEA-coated bypass circuits on perioperative inflammatory response Ann. Thorac. Surg., March 1, 2003; 75(3): 913 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Eichler, J F M. Bechtel, J. Schumacher, J. A Wermelt, K.-F. Klotz, and C. Bartels A rise of MMP-2 and MMP-9 in bronchoalveolar lavage fluid is associated with acute lung injury after cardiopulmonary bypass in a swine model Perfusion, March 1, 2003; 18(2): 107 - 113. [Abstract] [PDF] |
||||
![]() |
A. Parolari, S. Colli, L. Mussoni, S. Eligini, M. Naliato, X. Wang, S. Gandini, E. Tremoli, P. Biglioli, and F. Alamanni Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 336 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Ascione and G.D Angelini OPCAB surgery: a voyage of discovery back to the future Eur. Heart J., January 2, 2003; 24(2): 121 - 124. [Full Text] [PDF] |
||||
![]() |
R. Ascione, M. Caputo, and G. D. Angelini Off-pump coronary artery bypass grafting: not a flash in the pan Ann. Thorac. Surg., January 1, 2003; 75(1): 306 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, Y. Hiramatsu, S. Homma, S. Sato, M. Onizuka, and Y. Sakakibara Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 172 - 177. [Abstract] [Full Text] |
||||
![]() |
R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text] |
||||
![]() |
H.-H Sievers, C. Freund-Kaas, S. Eleftheriadis, T. Fischer, H. Kuppe, E. G. Kraatz, and J.F. M. Bechtel Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy Ann. Thorac. Surg., October 1, 2002; 74(4): 1167 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kessler, G. Neidhart, D. H. Bremerich, T. Aybek, S. Dogan, V. Lischke, and C. Byhahn High Thoracic Epidural Anesthesia for Coronary Artery Bypass Grafting Using Two Different Surgical Approaches in Conscious Patients Anesth. Analg., October 1, 2002; 95(4): 791 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Undar, H. C. Eichstaedt, F. J. Clubb Jr, M. Fung, M. Lu, J. E. Bigley, W. K. Vaughn, and C. D. Fraser Jr Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass Ann. Thorac. Surg., August 1, 2002; 74(2): 355 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
L H. Edmunds Jr The evolution of cardiopulmonary bypass: lessons to be learned Perfusion, July 1, 2002; 17(4): 243 - 251. [Abstract] [PDF] |
||||
![]() |
R. Ascione, S. Al-Ruzzeh, K. Amer, and G. D Angelini Subsystem organ function during coronary surgery Perfusion, July 1, 2002; 17(4): 295 - 303. [Abstract] [PDF] |
||||